Affinity Peptide Ligands for MPV Capsomer Purification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The existing methods for producing mouse polyomavirus virus-like particles (MPV VLPs) are hindered by the complexity and cost of removing the GST tag from the VP1 protein, limiting the scalability and application of MPV VLPs in vaccinology, gene therapy, and materials science.
Innovation Solution
Design and screening of novel affinity peptide ligands for MPV capsomers using in silico simulations, specifically constructing a peptide library based on the crystal structure of the VP2-C complex, identifying key residues, and employing molecular docking and dynamics simulations to select high-affinity peptide ligands like DWDLRLLY for affinity chromatography.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If GST tag is used to enhance soluble expression and ease of purification, then expression solubility and purification ease are improved, but operation complexity and cost increase due to enzymatic removal and additional separation steps
Solution Approach 1:
The invention extracts only the essential purification function by using affinity peptide ligands that directly bind to the target protein (VP1 or capsomers) without requiring a GST tag. This eliminates the need for enzymatic removal and additional separation steps, achieving simple purification operation while maintaining ease of manufacture
Solution Approach 2:
The affinity peptide ligands developed in this invention can universally bind to different forms of the target protein (VP1 monomer and capsomers) through specific amino acid sequences. This multi-functional capability allows direct purification without additional tags or enzymes, resolving the contradiction between purification ease and operation complexity
2Ease of manufacture
If GST tag with thrombin removal is used, then soluble expression is enhanced, but production cost increases due to expensive thrombin and additional purification steps
Solution Approach 1:
The invention replaces expensive thrombin enzyme and multiple purification steps with inexpensive affinity peptide ligands that can be directly immobilized on chromatography media. The peptide ligands serve as disposable, cost-effective purification agents that eliminate the need for costly enzymatic reactions and additional separation procedures
Solution Approach 2:
The invention changes the purification approach from enzymatic cleavage to direct affinity binding by modifying the ligand structure and binding parameters. The peptide ligands are designed with specific amino acid sequences that match the target protein's binding sites, enabling direct purification without enzymatic intervention and reducing production costs
3Reliability
If traditional affinity chromatography ligands are used, then target protein purification is achieved, but specificity and stability are limited compared to designed peptide ligands
Solution Approach 1:
The invention performs preliminary computational design and screening of peptide ligands using molecular docking simulations before actual purification. This preliminary action identifies optimal peptide sequences with high specificity and stability, ensuring reliable purification while maintaining manufacturing simplicity through in silico optimization
Solution Approach 2:
The invention replaces traditional empirical ligand selection with computational molecular docking and simulation methods. This substitution of mechanical/empirical approach with computational analysis enables precise prediction of ligand-protein interactions, achieving high specificity and stability while keeping ligand production simple through rational design
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The novel affinity peptide ligands demonstrate high specificity and stability, enabling efficient purification of MPV capsomers with improved chromatographic separation and potential for broader applications in biotechnology.
Implementation Method 1
The C-terminus of VP2 (thereafter termed VP2-C) binds in an unusual, hairpin-like manner into the inner surface of Cap through hydrophobic interactions
Implementation Method 2
Affinity chromatography capable of separating and purifying a target molecule by interaction between biomacromolecules and specificity ligands
Data Source
AI summary
Affinity peptide ligands of mouse polyomavirus capsomers and a designed screening method thereof. The affinity peptide ligands can be used for separation and purification of the capsomers.